New Key Statistics Module, Z-Score and F-Score
NAS:HRMY Key Ratios
Market Cap $ M | 2,145.51 |
Enterprise Value $ M | 1,958.31 |
P/E(ttm) | 19.12 |
PE Ratio without NRI | 15.87 |
Forward PE Ratio | 10.13 |
Price/Book | 3.93 |
Price/Sales | 3.33 |
Price/Free Cash Flow | 10.31 |
Price/Owner Earnings | 65.63 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 656.00 |
EPS (TTM) $ | 1.95 |
Beneish M-Score | -2.61 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 24.80 |
EV-to-EBIT | 10.18 |
EV-to-EBITDA | 9.04 |
PEG | -- |
Shares Outstanding M | 56.83 |
Net Margin (%) | 17.53 |
Operating Margin % | 27.14 |
Pre-tax Margin (%) | 25.15 |
Quick Ratio | 3.09 |
Current Ratio | 3.13 |
ROA % (ttm) | 14.18 |
ROE % (ttm) | 23.11 |
ROIC % (ttm) | 32.16 |
Dividend Yield % | -- |
Altman Z-Score | 5.76 |
HRMY Number of Guru Trades
HRMY Volume of Guru Trades
Gurus Latest Trades with NAS:HRMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HRMY is held by these investors
Total 2
Harmony Biosciences Holdings Inc Insider Transactions
No Available Data
News about NAS:HRMY
Total 0- 1